Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BMV suspends JPMorgan Global Core Real Assets (JARA N) trading on SIC Capitales after London Stock Exchange delisting

BMV suspends JPMorgan Global Core Real Assets (JARA N) trading on SIC Capitales after London Stock Exchange delisting

ReutersReuters2026/08/27 13:28
  • BMV suspended trading of JPMorgan Global Core Real Assets (JARA “N”) in the SIC Capitales segment of its International Quotation System.
  • The halt follows a suspension on the London Stock Exchange tied to the stock’s delisting there.
  • BMV said it will seek CNBV authorization to cancel the instrument’s SIC Capitales listing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BMV - Bolsa Mexicana de Valores SA de CV published the original content used to generate this news brief on August 27, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y

As traditional automakers cut back on their loss-making electric vehicle businesses, Tesla (TSLA.US) has regained more than half of the US electric vehicle market share.

智通财经2026/09/14 01:06
The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas